KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Prepaid Assets (2017 - 2025)

Bionano Genomics' Prepaid Assets history spans 7 years, with the latest figure at $5.4 million for Q3 2025.

  • For Q3 2025, Prepaid Assets rose 22.59% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $5.4 million, up 22.59%, while the annual FY2024 figure was $3.1 million, 221.82% up from the prior year.
  • Prepaid Assets for Q3 2025 was $5.4 million at Bionano Genomics, up from $3.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.3 million in Q4 2022 and bottomed at $976000.0 in Q4 2023.
  • The 5-year median for Prepaid Assets is $4.4 million (2024), against an average of $4.4 million.
  • The largest annual shift saw Prepaid Assets tumbled 86.68% in 2023 before it skyrocketed 221.82% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $4.5 million in 2021, then soared by 63.56% to $7.3 million in 2022, then crashed by 86.68% to $976000.0 in 2023, then surged by 221.82% to $3.1 million in 2024, then soared by 71.22% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Prepaid Assets are $5.4 million (Q3 2025), $3.1 million (Q2 2025), and $2.8 million (Q1 2025).